Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l
Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision suc...
Gespeichert in:
Veröffentlicht in: | Stem cells (Dayton, Ohio) Ohio), 2019-01, Vol.37 (1), p.115-127 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 127 |
---|---|
container_issue | 1 |
container_start_page | 115 |
container_title | Stem cells (Dayton, Ohio) |
container_volume | 37 |
creator | Yin, Bei Yu, Fanyuan Wang, Chenglin Li, Boer Liu, Mengyu Ye, Ling |
description | Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127
Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ. |
doi_str_mv | 10.1002/stem.2918 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2115279462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2161869097</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</originalsourceid><addsrcrecordid>eNp10DtPwzAUBWALgSivgT-ALLHAkGI7tmOPqJSHBGKgjChy3BtqlMTFTkH997i0MCAx-Q6fjo4PQseUDCkh7CL20A6ZpmoL7VHBdcbTvZ1uImUmiNYDtB_jGyGUC6V20SAnrCC8UHvoZTx3r9BB7ywe-a4PvsG-xg8QobOzZWsa_JTS8QiaBl-bHvAVWBed7_CHM_jWxd53kHw_WzZ9MF2sIZgI-DLOaHOIdmrTRDjavAfo-Xo8Gd1m9483d6PL-8zmSqmMMssqqzgXq09oKaagpxUYVXNRU2Iro4jRVZVLEFJQqGVuC1tow7ixwPP8AJ2tc-fBvy8g9mXrok2VTQd-EUtGqWCF5pIlevqHvvlF6FK7pCRVUhNdJHW-Vjb4GAPU5Ty41oRlSUm52rxcbV6u6iZ7sklcVC1Mf-XPyAlcrMGna2D5f1L5NBk_fEd-AQcBi2E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161869097</pqid></control><display><type>article</type><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</creator><creatorcontrib>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</creatorcontrib><description>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127
Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</description><identifier>ISSN: 1066-5099</identifier><identifier>EISSN: 1549-4918</identifier><identifier>DOI: 10.1002/stem.2918</identifier><identifier>PMID: 30270478</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Adipogenesis ; Animals ; Arthritis ; Biocompatibility ; Biomedical materials ; Bone mass ; Bones ; Cartilage ; Cell Differentiation ; Cell fate ; Cells (biology) ; Chondrogenesis ; Differentiation ; DNA-Binding Proteins - genetics ; DNA-Binding Proteins - metabolism ; Epigenesis, Genetic - genetics ; Epigenetics ; Hematopoietic stem cells ; Histone methyltransferase ; Histone Methyltransferases - genetics ; Histone-Lysine N-Methyltransferase - genetics ; Histone-Lysine N-Methyltransferase - metabolism ; Humans ; Keratinocytes ; Lysine ; Mesenchymal stem cells ; Mesenchymal stem cells (MSCs) ; Mesenchymal Stem Cells - metabolism ; Mesenchyme ; Mice ; Osteogenesis ; Osteoporosis ; Progenitor cells ; Stem cell transplantation ; Stem cells ; Transcription factors ; Transfection ; Transplantation</subject><ispartof>Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.115-127</ispartof><rights>AlphaMed Press 2018</rights><rights>AlphaMed Press 2018.</rights><rights>2019 AlphaMed Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</citedby><cites>FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30270478$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yin, Bei</creatorcontrib><creatorcontrib>Yu, Fanyuan</creatorcontrib><creatorcontrib>Wang, Chenglin</creatorcontrib><creatorcontrib>Li, Boer</creatorcontrib><creatorcontrib>Liu, Mengyu</creatorcontrib><creatorcontrib>Ye, Ling</creatorcontrib><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><title>Stem cells (Dayton, Ohio)</title><addtitle>Stem Cells</addtitle><description>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127
Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</description><subject>Adipogenesis</subject><subject>Animals</subject><subject>Arthritis</subject><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Bone mass</subject><subject>Bones</subject><subject>Cartilage</subject><subject>Cell Differentiation</subject><subject>Cell fate</subject><subject>Cells (biology)</subject><subject>Chondrogenesis</subject><subject>Differentiation</subject><subject>DNA-Binding Proteins - genetics</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Epigenesis, Genetic - genetics</subject><subject>Epigenetics</subject><subject>Hematopoietic stem cells</subject><subject>Histone methyltransferase</subject><subject>Histone Methyltransferases - genetics</subject><subject>Histone-Lysine N-Methyltransferase - genetics</subject><subject>Histone-Lysine N-Methyltransferase - metabolism</subject><subject>Humans</subject><subject>Keratinocytes</subject><subject>Lysine</subject><subject>Mesenchymal stem cells</subject><subject>Mesenchymal stem cells (MSCs)</subject><subject>Mesenchymal Stem Cells - metabolism</subject><subject>Mesenchyme</subject><subject>Mice</subject><subject>Osteogenesis</subject><subject>Osteoporosis</subject><subject>Progenitor cells</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Transcription factors</subject><subject>Transfection</subject><subject>Transplantation</subject><issn>1066-5099</issn><issn>1549-4918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10DtPwzAUBWALgSivgT-ALLHAkGI7tmOPqJSHBGKgjChy3BtqlMTFTkH997i0MCAx-Q6fjo4PQseUDCkh7CL20A6ZpmoL7VHBdcbTvZ1uImUmiNYDtB_jGyGUC6V20SAnrCC8UHvoZTx3r9BB7ywe-a4PvsG-xg8QobOzZWsa_JTS8QiaBl-bHvAVWBed7_CHM_jWxd53kHw_WzZ9MF2sIZgI-DLOaHOIdmrTRDjavAfo-Xo8Gd1m9483d6PL-8zmSqmMMssqqzgXq09oKaagpxUYVXNRU2Iro4jRVZVLEFJQqGVuC1tow7ixwPP8AJ2tc-fBvy8g9mXrok2VTQd-EUtGqWCF5pIlevqHvvlF6FK7pCRVUhNdJHW-Vjb4GAPU5Ty41oRlSUm52rxcbV6u6iZ7sklcVC1Mf-XPyAlcrMGna2D5f1L5NBk_fEd-AQcBi2E</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Yin, Bei</creator><creator>Yu, Fanyuan</creator><creator>Wang, Chenglin</creator><creator>Li, Boer</creator><creator>Liu, Mengyu</creator><creator>Ye, Ling</creator><general>John Wiley & Sons, Inc</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201901</creationdate><title>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</title><author>Yin, Bei ; Yu, Fanyuan ; Wang, Chenglin ; Li, Boer ; Liu, Mengyu ; Ye, Ling</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-12c2bc84452918965de9dbea8f45f10cba80a9bb36e5651ef63c7c79a24ace433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adipogenesis</topic><topic>Animals</topic><topic>Arthritis</topic><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Bone mass</topic><topic>Bones</topic><topic>Cartilage</topic><topic>Cell Differentiation</topic><topic>Cell fate</topic><topic>Cells (biology)</topic><topic>Chondrogenesis</topic><topic>Differentiation</topic><topic>DNA-Binding Proteins - genetics</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Epigenesis, Genetic - genetics</topic><topic>Epigenetics</topic><topic>Hematopoietic stem cells</topic><topic>Histone methyltransferase</topic><topic>Histone Methyltransferases - genetics</topic><topic>Histone-Lysine N-Methyltransferase - genetics</topic><topic>Histone-Lysine N-Methyltransferase - metabolism</topic><topic>Humans</topic><topic>Keratinocytes</topic><topic>Lysine</topic><topic>Mesenchymal stem cells</topic><topic>Mesenchymal stem cells (MSCs)</topic><topic>Mesenchymal Stem Cells - metabolism</topic><topic>Mesenchyme</topic><topic>Mice</topic><topic>Osteogenesis</topic><topic>Osteoporosis</topic><topic>Progenitor cells</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Transcription factors</topic><topic>Transfection</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yin, Bei</creatorcontrib><creatorcontrib>Yu, Fanyuan</creatorcontrib><creatorcontrib>Wang, Chenglin</creatorcontrib><creatorcontrib>Li, Boer</creatorcontrib><creatorcontrib>Liu, Mengyu</creatorcontrib><creatorcontrib>Ye, Ling</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Stem cells (Dayton, Ohio)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yin, Bei</au><au>Yu, Fanyuan</au><au>Wang, Chenglin</au><au>Li, Boer</au><au>Liu, Mengyu</au><au>Ye, Ling</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l</atitle><jtitle>Stem cells (Dayton, Ohio)</jtitle><addtitle>Stem Cells</addtitle><date>2019-01</date><risdate>2019</risdate><volume>37</volume><issue>1</issue><spage>115</spage><epage>127</epage><pages>115-127</pages><issn>1066-5099</issn><eissn>1549-4918</eissn><abstract>Previous research indicates that knocking out absent, small, or homeotic‐like (Ash1l) in mice, a histone 3 lysine 4 (H3K4) trimethyltransferase, can result in arthritis with more severe cartilage and bone destruction. Research has documented the essential role of Ash1l in stem cell fate decision such as hematopoietic stem cells and the progenitors of keratinocytes. Following up on those insights, our research seeks to document the function of Ash1l in skeletal formation, specifically whether it controls the fate decision of mesenchymal progenitor cells. Our findings indicate that in osteoporotic bones, Ash1l was significantly decreased, indicating a positive correlation between bone mass and the expression of Ash1l. Silencing of Ash1l that had been markedly upregulated in differentiated C3H10T1/2 (C3) cells hampered osteogenesis and chondrogenesis but promoted adipogenesis. Consistently, overexpression of an Ash1l SET domain‐containing fragment 3 rather than Ash1lΔN promoted osteogenic and chondrogenic differentiation of C3 cells and simultaneously inhibited adipogenic differentiation. This indicates that the role of Ash1l in regulating the differentiation of C3 cells is linked to its histone methyltransferase activity. Subcutaneous ex vivo transplantation experiments confirmed the role of Ash1l in the promotion of osteogenesis. Further experiments proved that Ash1l can epigenetically affect the expression of essential osteogenic and chondrogenic transcription factors. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Considering the promotional action of Ash1l on bone, it could potentially prompt new therapeutic strategy to promote osteogenesis. Stem Cells 2019;37:115–127
Ash1l can epigenetically promote the expression of essential osteogenic and chondrogenic transcription factors in C3H10T1/2 cells. It exerts this impact via modifications in the enrichment of H3K4me3 on their promoter regions. Ash1l hampered adipogenesis by enhancing H3K4me3 enrichment in promoter of Creb gene, which was reported to be a repressive gene of PPARγ.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>30270478</pmid><doi>10.1002/stem.2918</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1066-5099 |
ispartof | Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.115-127 |
issn | 1066-5099 1549-4918 |
language | eng |
recordid | cdi_proquest_miscellaneous_2115279462 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Adipogenesis Animals Arthritis Biocompatibility Biomedical materials Bone mass Bones Cartilage Cell Differentiation Cell fate Cells (biology) Chondrogenesis Differentiation DNA-Binding Proteins - genetics DNA-Binding Proteins - metabolism Epigenesis, Genetic - genetics Epigenetics Hematopoietic stem cells Histone methyltransferase Histone Methyltransferases - genetics Histone-Lysine N-Methyltransferase - genetics Histone-Lysine N-Methyltransferase - metabolism Humans Keratinocytes Lysine Mesenchymal stem cells Mesenchymal stem cells (MSCs) Mesenchymal Stem Cells - metabolism Mesenchyme Mice Osteogenesis Osteoporosis Progenitor cells Stem cell transplantation Stem cells Transcription factors Transfection Transplantation |
title | Epigenetic Control of Mesenchymal Stem Cell Fate Decision via Histone Methyltransferase Ash1l |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A57%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epigenetic%20Control%20of%20Mesenchymal%20Stem%20Cell%20Fate%20Decision%20via%20Histone%20Methyltransferase%20Ash1l&rft.jtitle=Stem%20cells%20(Dayton,%20Ohio)&rft.au=Yin,%20Bei&rft.date=2019-01&rft.volume=37&rft.issue=1&rft.spage=115&rft.epage=127&rft.pages=115-127&rft.issn=1066-5099&rft.eissn=1549-4918&rft_id=info:doi/10.1002/stem.2918&rft_dat=%3Cproquest_cross%3E2161869097%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161869097&rft_id=info:pmid/30270478&rfr_iscdi=true |